World Biotechnology

Synthetic Biology that lowers the cost of industrial bioproduction and biopharmaceuticals

World Biotechnology is a synthetic biology company that will lower the cost of production in pharmaceuticals, biofuels, chemicals, nutraceuticals, and agribusiness, and reduce the carbon footprint along the way. WB has developed a proprietary technology to enable microorganisms to be significantly more efficient in the production of pharmaceutical drugs, biofuels, oils, and any products made through bioprocessing. DIRECT LIGHT TECHNOLOGY World Biotechnology’s core innovation is the patented Direct Light Technology. DLT is a synthetic biology platform that, when integrated into microorganisms such as yeast, mammalian cell lines, algae, and cyanobacteria, used in industrial biotechnology production processes, significantly improves the efficiency of the process, resulting in greater yields and shorter production cycles. DLT converts light directly into chemical energy with several orders of magnitude greater efficiency than photosynthesis and normal metabolism, even under near dark conditions. Some of the benefits to the customer of using DLT include: • Shorter production cycles, increased productivity, titer, and yield. • Improved energy efficiency. • Reduced dependency on fluctuating feedstock costs by replacing traditional carbon source with CO2. • Lower fixed and variable operating costs, higher margins. • Increased production capacity with smaller footprint.